Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             550 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abdominal wall closure after TRAM-use of large mesh — Experience with 50 patients Moscona, R.
 1998
 34 S5 p. S29-
1 p.
 artikel
2 Accumulation of p53 is associated with response to pre-operative chemotherapy in primary operable breast cancer van Slooten, H.-J.
 1998
 34 S5 p. S31-
1 p.
 artikel
3 Accuracy of dynamic contrast-enhanced MR imaging in patients with indeterminate mammograms Imbriaco, M.
 1998
 34 S5 p. S73-
1 p.
 artikel
4 Accuracy of endoscopie axillary lymph node dissection in breast cancer patients Kühn, T.
 1998
 34 S5 p. S48-
1 p.
 artikel
5 A classification of breast cancer based on contrast enhanced MRI Douek, M.
 1998
 34 S5 p. S96-
1 p.
 artikel
6 A clinical comparative study of adjuvant therapy after breast conserving surgery for early breast cancer Tominaga, T.
 1998
 34 S5 p. S52-
1 p.
 artikel
7 A combination therapy with mitomycin-C, etoposide, doxifluridine and medroxyprogesterone acetate as second-line therapy for advanced breast cancer Osaki, A.
 1998
 34 S5 p. S16-
1 p.
 artikel
8 A comparison of biochemical quantitative and immunohistochemical detection methods for the detection of the erbB2 oncoprotein in breast cancer tissue Giersig, C.
 1998
 34 S5 p. S103-
1 p.
 artikel
9 A comparison of body image in post-mastectomy and breast reconstruction patients Hopwood, P.
 1998
 34 S5 p. S123-
1 p.
 artikel
10 Activity of chemotherapy based on Navelbine in pre-treated metastatic breast cancer patients Leusik, A.
 1998
 34 S5 p. S17-
1 p.
 artikel
11 Activity of exemestane, an irreversible, oral, aromatase inhibitor in metastatic postrnenopausal breast cancer patients (MBC) failing tamoxifen (TAM) Kvinnsland, S.
 1998
 34 S5 p. S91-
1 p.
 artikel
12 Acute reactions and cosmetic outcome after conservative surgery and adjuvant RT in stage I–II breast cancer Valli, M.C.
 1998
 34 S5 p. S60-
1 p.
 artikel
13 Adenoid cystic carcinoma of the breast: About 14 new cases Vlastos, G.
 1998
 34 S5 p. S114-
1 p.
 artikel
14 Adjuvant chemotherapy for breast cancer patients: Patients' expectations and physicians attitudes Kreitler, Shulamith
 1998
 34 S5 p. S63-
1 p.
 artikel
15 Adjuvant CMF +/− tamoxifen (TAM) in premenopausal high-risk patients (PHRPs) with early breast cancer Andersson, M.
 1998
 34 S5 p. S40-
1 p.
 artikel
16 Adjuvant Goserelin depot in premenopausal women with early breast cancer: Ovarian function, bone mineral density and survival. Preliminary data De Matteis, A.
 1998
 34 S5 p. S42-
1 p.
 artikel
17 Adjuvant systemic treatment for operable breast cancer — Standard therapies and new approaches Goldhirsch, A.
 1998
 34 S5 p. S88-
1 p.
 artikel
18 Adjuvant therapy: patient issues Jones, A.
 1998
 34 S5 p. S88-
1 p.
 artikel
19 Adrenomedullin: A potential autocrine growth factor for human breast epithelial cells during development and carcinogenesis Miller, J.M.
 1998
 34 S5 p. S83-
1 p.
 artikel
20 Advanced breast biopsy instrumentation (ABBI): Initial experience Nogaret, J.M.
 1998
 34 S5 p. S72-
1 p.
 artikel
21 Aesthetic results of the breast cancer conservative treatment in the lower quadrants Calabrese, C.
 1998
 34 S5 p. S26-
1 p.
 artikel
22 After mastectomy: Breast reconstruction. The nurse's counselling role Ferrario, Regina
 1998
 34 S5 p. S27-
1 p.
 artikel
23 Age the limiting factor for breast conservative treatment in T1 breast cancer? Jobsen, Jan J.
 1998
 34 S5 p. S101-
1 p.
 artikel
24 Aggressive fibromatosis of the breast. Clinical, pathological & mammographic findings Govoni, A.F.
 1998
 34 S5 p. S115-
1 p.
 artikel
25 A model of elderly Latina's breast screening decisions Veit, C.
 1998
 34 S5 p. S94-
1 p.
 artikel
26 Analysis of 47 breast lesions screen detected treated by surgical biopsy: Surgical margin status and presence of residual tumor at the surgical reexcision Cuccorese, C.
 1998
 34 S5 p. S113-
1 p.
 artikel
27 Analysis of serum lgG1 in patients with benign and malignant breast disease Kornberger, L
 1998
 34 S5 p. S75-
1 p.
 artikel
28 Analysis of variables associated with recurrence/metastasis in breast cancer tumor of ≤1cm Tubiana-Hulin, M.
 1998
 34 S5 p. S98-
1 p.
 artikel
29 An assessment of anxiety levels of women attending for the first outpatient appointment for breast care Durning, P.
 1998
 34 S5 p. S124-
1 p.
 artikel
30 A national pathology audit of breast cancer cases Kricker, A.
 1998
 34 S5 p. S112-
1 p.
 artikel
31 An audit of grading and typing of invasive breast carcinoma on needlecore biopsy specimens Denley, H.E.
 1998
 34 S5 p. S111-
1 p.
 artikel
32 Androstenedione (A) conversion in lymphocytes infiltrating breast cancer (BC) tissue Berstein, L.M.
 1998
 34 S5 p. S83-S84
2 p.
 artikel
33 A new scoring system to evaluate the malignancy risk in mammographic microcalcifications Kinget, K.
 1998
 34 S5 p. S72-
1 p.
 artikel
34 A new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT) Klijn, J.G.M.
 1998
 34 S5 p. S90-
1 p.
 artikel
35 Anti-apoptotic phenotype is associated with decreased loco-regional recurrence rate in breast cancer Jager, J.J.
 1998
 34 S5 p. S99-S100
2 p.
 artikel
36 Antitumor effects of 22-oxa-calcitriol on MDA-MB-231 tumors in athymic mice Matsumoto, H.
 1998
 34 S5 p. S22-
1 p.
 artikel
37 A pathway for a woman: Global approach to breast cancer Russo, F. Mastrogiacomo
 1998
 34 S5 p. S78-
1 p.
 artikel
38 A pathway of care to clinical effectiveness and service efficiency McIlvenny, C.
 1998
 34 S5 p. S67-
1 p.
 artikel
39 A patient model of effective communication for screening mammography Fox, S.
 1998
 34 S5 p. S63-
1 p.
 artikel
40 A phase II study of a potent and selective aromatase inhibitor, anastrozole (ZD-1033), in Japanese postmenopausal women with advanced/recurrent breast cancer Koyama, H.
 1998
 34 S5 p. S21-
1 p.
 artikel
41 Apoptosis in ductal carcinoma in situ of the breast: its relationship to prognostic markers Moreno, A.
 1998
 34 S5 p. S10-
1 p.
 artikel
42 A proposed prognostic factor for node-negative invasive breast carcinomas: Evaluation based on the intraductal component, particularly the presence of comedo-type necrosis Yagata, H.
 1998
 34 S5 p. S105-
1 p.
 artikel
43 A prospective assessment of magnetic resonance mammography (MRM) with conventional triple assessment in symptomatic breast disease Chatteriee, S.
 1998
 34 S5 p. S70-
1 p.
 artikel
44 A prospective study of intra-operative localisation of sentinel lymph node in patients with breast cancer using dye technique El Gammal, M.
 1998
 34 S5 p. S47-
1 p.
 artikel
45 A prospective study of sentinel lymph node in patients with breast cancer using a combined technique: Dye and radio-labelled colloid El Gammal, M.M.
 1998
 34 S5 p. S51-
1 p.
 artikel
46 A prospective study on genetic risk factors in an unselected sample of breast cancer patients who receive adjuvant radiotherapy Wárlám-Rodenhuis, C.C.
 1998
 34 S5 p. S118-S119
2 p.
 artikel
47 A pure antiestrogen, IC1182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in female nude mice Kurebavashi, J.
 1998
 34 S5 p. S83-
1 p.
 artikel
48 A randomised clinical trial of primary chemotherapy (PC) with taxol + epirubicin (TE) V. 5-FU + epirubicin + cyclophosphamide (FEC) in stage IIIA breast cancer: A preliminary report Malamos, N.
 1998
 34 S5 p. S14-S15
2 p.
 artikel
49 A randomized phase III trial of adjuvant endocrine therapy with tamoxifen for one year (TAM1) vs tamoxifen for two years (TAM2) in postmenopausal high risk patients with estrogen receptor positive or estrogen receptor unknown breast cancer. A DBCG study Andersen, J.
 1998
 34 S5 p. S41-S42
2 p.
 artikel
50 Are risk factors for local and distant recurrence following breast-conserving therapy for early breast cancer similar to those following mastectomy? Voogd, A.C.
 1998
 34 S5 p. S46-
1 p.
 artikel
51 A rigorus follow-up study is necessary to precisely estimate the effect of adjuvant therapy in early breast cancer Nomura, Y.
 1998
 34 S5 p. S25-
1 p.
 artikel
52 Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer Houghton, J.
 1998
 34 S5 p. S83-
1 p.
 artikel
53 Arm morbidity after primary breast cancer treatment in elderly women Tengrup, I.
 1998
 34 S5 p. S127-
1 p.
 artikel
54 Arm morbidity in 131 women with small breast tumours (up to 10 mm) who all had level 2 axillary clearance Stallard, S.
 1998
 34 S5 p. S54-
1 p.
 artikel
55 Assessing the psychological functioning and health care choices of adolescent daughters of breast cancer patients Cappelli, M.
 1998
 34 S5 p. S122-
1 p.
 artikel
56 Assessment of the response with color-doppler sonography (CDS) in patients affected by breast cancer (BC) in neoadjuvant chemotherapy (NCT) Filippelli, G.
 1998
 34 S5 p. S107-
1 p.
 artikel
57 A study of correlation between DNA ploidy pattern and aberration of Chromosome 8 detected by fluorescence in situ hybridization in human breast cancer Hara, S.
 1998
 34 S5 p. S119-
1 p.
 artikel
58 A study of molecular markers with potential prognostic and predictive value (c-erb b-2, p53, cyclin D1, MIB1, ER and PgR) in locally advanced breast cancer treated with neo-adjuvant dose intensive chemotherapy in an EORTC-NCIC-SAKK randomized phase III study Bonnefoi, H.
 1998
 34 S5 p. S30-
1 p.
 artikel
59 Attitudes of medical students towards a woman with metastatic breast cancer Cheung, K.L.
 1998
 34 S5 p. S121-
1 p.
 artikel
60 Author index 1998
 34 S5 p. S129-S138
10 p.
 artikel
61 Axillary dissection in stage i breast cancer Brondi, L.A.G.
 1998
 34 S5 p. S55-
1 p.
 artikel
62 Axillary node involvement in T1 breast cancer in pre-menopausal Chinese Hsu, M.H.
 1998
 34 S5 p. S104-
1 p.
 artikel
63 Axillary staging of T1-T2 breast cancer Sandrucci, S.
 1998
 34 S5 p. S70-
1 p.
 artikel
64 Axillary surgery in patients with breast cancer being treated by breast conservation: A randomised trial of node sample or axillary clearance Chetty, U.
 1998
 34 S5 p. S47-
1 p.
 artikel
65 A 5-year audit of breast cancer treatment in the very elderly (85+ years) Vestey, S.
 1998
 34 S5 p. S127-
1 p.
 artikel
66 BIG — The breast intergroup Piccart, Martine J.
 1998
 34 S5 p. S88-
1 p.
 artikel
67 Biologic markers in small cancers of the breast and breast preneoplastic lesions Krogerus, Leena
 1998
 34 S5 p. S113-
1 p.
 artikel
68 ‘Blind’ review of interval breast cancers de Rilke, J.M.
 1998
 34 S5 p. S68-
1 p.
 artikel
69 Bottle-necks in Dutch breast cancer care Taselaar-Benes, E.
 1998
 34 S5 p. S65-
1 p.
 artikel
70 Breast cancer and missense mutations in the transactivation region of the BRCA1 gene Garcia, J.M.
 1998
 34 S5 p. S118-
1 p.
 artikel
71 Breast cancer and risk factors: A comparative study between a low and a high risk population Straccia, A.T.
 1998
 34 S5 p. S24-
1 p.
 artikel
72 Breast cancer — A new technique of reconstruction Nemsadze, G.
 1998
 34 S5 p. S27-
1 p.
 artikel
73 Breast cancer care: Does the NHS discriminate against women living in deprived areas? Macleod, U.
 1998
 34 S5 p. S74-
1 p.
 artikel
74 Breast cancer clinical trials in Europe — What has been done and what is currently underway Castiglione-Gertsch, M.
 1998
 34 S5 p. S128-
1 p.
 artikel
75 Breast cancer clinical trials with Faslodex — A new class of antioestrogen Howell, A.
 1998
 34 S5 p. S19-
1 p.
 artikel
76 Breast cancer in elderly patients: Psychosocial aspects of rehabilitation Strada, M.
 1998
 34 S5 p. S123-
1 p.
 artikel
77 Breast cancer in Europe — Why outcomes are different? Burns, H.
 1998
 34 S5 p. S89-
1 p.
 artikel
78 Breast cancer in old Romanian women Onofriescu, M.
 1998
 34 S5 p. S127-
1 p.
 artikel
79 Breast cancer in premenopausal women/should mastectomy be recommended? de la Rochefordière, A.
 1998
 34 S5 p. S59-
1 p.
 artikel
80 Breast cancer in the elderly. The impact of histological features on the prognosis and survival Botos, Á.
 1998
 34 S5 p. S126-
1 p.
 artikel
81 Breast cancer patients treated without axillary surgery: Clinical implications and biological analysis Greco, M.
 1998
 34 S5 p. S45-
1 p.
 artikel
82 Breast cancer screening Amadori, D.
 1998
 34 S5 p. S91-
1 p.
 artikel
83 Breast cancer: The nurse's role in genetic counselling Ferrario, Regina
 1998
 34 S5 p. S66-
1 p.
 artikel
84 Breast cancer tissue analysis by computerized bidimensional polyacrylamide gel electrophoresis (2DPAGE) and N-terminal microsequencing Bini, L.
 1998
 34 S5 p. S117-
1 p.
 artikel
85 Breast cancer under age 35 — In what way should we treat the patients Jeziorski, A.Z.
 1998
 34 S5 p. S109-
1 p.
 artikel
86 Breast conservation therapy — techniques & controversies O'Higgins, Niall
 1998
 34 S5 p. S4-
1 p.
 artikel
87 Breast conservation without axillary dissection Galimberti, V.
 1998
 34 S5 p. S36-
1 p.
 artikel
88 Breast conserving operations, frequency of vessels invasion, and disease free survival of the breast cancer T1–2N0–1N0 patients Portnoi, S.M.
 1998
 34 S5 p. S52-
1 p.
 artikel
89 Breast-conserving therapy in case of carcinoma tumours larger than 2 cm with the help of individually adapted oncoplastic operations Schöndorf, N.K.
 1998
 34 S5 p. S51-S52
2 p.
 artikel
90 Breast conserving therapy in stage I and II breast cancer Rancˇić, Z.
 1998
 34 S5 p. S56-
1 p.
 artikel
91 Breast metastasis as the first sign of a gastric adenocarcinoma Baratelli, G.M.
 1998
 34 S5 p. S74-
1 p.
 artikel
92 Breast reconstruction (BR) in breast cancer (BC) patients Blokhin, S.N.
 1998
 34 S5 p. S28-
1 p.
 artikel
93 Breast reconstruction by TRAM flap: Technical options Santi, P.L.
 1998
 34 S5 p. S25-S26
2 p.
 artikel
94 Breast reconstruction with free microvascular TRAM flap von Smitten, K.
 1998
 34 S5 p. S27-
1 p.
 artikel
95 Breast sarcoma and carcinosarcoma in the material of Cancer Center-Institute in Warsaw, Poland Niwińska, A.
 1998
 34 S5 p. S54-
1 p.
 artikel
96 Breast self examination proficiency in older Black and White women: Efficacy of video self instruction Wood, R.Y.
 1998
 34 S5 p. S64-
1 p.
 artikel
97 “BSE RAP”: The evaluation of a breast self-examination music program, developed to create breast health awareness among teens and their families Ehmann, Johanna Lombardo
 1998
 34 S5 p. S64-
1 p.
 artikel
98 Can assessment of angiogenesis, proliferation and apoptosis predict the need for adjuvant therapy in breast cancer? van Dam, P.
 1998
 34 S5 p. S100-
1 p.
 artikel
99 Can population based screening reduce the mortality from breast cancer? Kingsmore, D.B.
 1998
 34 S5 p. S93-
1 p.
 artikel
100 Can the mortality of breast cancer be reduced? Kingsmore, D.B.
 1998
 34 S5 p. S95-S96
2 p.
 artikel
101 CA-15.3: Prognostic factor in breast cancer Vialard, F.
 1998
 34 S5 p. S100-
1 p.
 artikel
102 Care across the continuum — The Breast Care Nurse in Australia Lewis, M.
 1998
 34 S5 p. S67-S68
2 p.
 artikel
103 Caring About Women and Cancer (CAWAC): The perceptions, experiences and evaluation of cancer care among European women von Kleist, S.
 1998
 34 S5 p. S64-
1 p.
 artikel
104 Case report: Primary neuroendocrine tumour of the breast Vernet, M.
 1998
 34 S5 p. S115-
1 p.
 artikel
105 Ceiling paintings above patients being examined reduce anxieties Baratelli, G.M.
 1998
 34 S5 p. S124-S125
2 p.
 artikel
106 Cellbiological factors in relation to nuclear grade and growth pattern Fernö, M.
 1998
 34 S5 p. S114-
1 p.
 artikel
107 Change in expression of ER and BCL-2 predict for quality and duration of response in endocrine sensitive breast cancer Kenny, F.S.
 1998
 34 S5 p. S82-
1 p.
 artikel
108 Change of Cu/Zn-superoxide dismutase in breast cancer tissue related to the tumor proliferation and differentiation being one of prognostic indicators Yamamoto, H.
 1998
 34 S5 p. S108-
1 p.
 artikel
109 Changes in biochemical markers of bone turnover in breast cancer patients with bone metastases Vrbanec, D.
 1998
 34 S5 p. S15-S16
2 p.
 artikel
110 Changing concepts in breast cancer management Veronesi, U.
 1998
 34 S5 p. S3-
1 p.
 artikel
111 Characteristics of breast cancer in elderly women Djordjević, M.
 1998
 34 S5 p. S127-
1 p.
 artikel
112 Chemoprevention of breast cancer — An update Cuzick, J.
 1998
 34 S5 p. S23-
1 p.
 artikel
113 CIP-1 Protein expression in node-positive breast cancer patients Hupperets, P.
 1998
 34 S5 p. S119-
1 p.
 artikel
114 Classification of ductal carcinoma in situ of the breast in the EORTC 10853 trial: Do subtypes predict risk of recurrence? Results of the central pathology review of the EORTC 10853 DCIS trial Bilker, N.
 1998
 34 S5 p. S8-
1 p.
 artikel
115 Clinical significance of rapid scraping cytology to ensure the cancer free margin in breast conserving surgery Mivauchi, M.
 1998
 34 S5 p. S55-
1 p.
 artikel
116 Clinical usefulness of preoperative evaluation of mammary tumours with99mTc-sestamibi imaging Leppanen, E.
 1998
 34 S5 p. S77-
1 p.
 artikel
117 CMF and mitoxantrone in elderly patients with advanced breast cancer. A randomized phase II study Nooij, M.A.
 1998
 34 S5 p. S91-
1 p.
 artikel
118 Colour and power Doppler in the differential diagnosis of breast tumours: Correlation with microvessel density and blood vessel counts Tehl, W.L
 1998
 34 S5 p. S68-S69
2 p.
 artikel
119 Combination chemotherapy with paclitaxel (T) and epirubicin (E) for metastatic breast cancer (MBC): A phase I–II study Durando, A.
 1998
 34 S5 p. S12-S13
2 p.
 artikel
120 Combination of antimetastatic and antiproliferative therapies in the treatment of experimental breast cancer Setyono-Han, B.
 1998
 34 S5 p. S19-
1 p.
 artikel
121 Combination of oral idarubicin and cyclophosphamide in the treatment of advanced breast cancer Wiltschke, C.
 1998
 34 S5 p. S12-
1 p.
 artikel
122 Communication skills of oncologists Fallowfield, Lesley J.
 1998
 34 S5 p. S62-
1 p.
 artikel
123 Comparative studies on cytological findings between early recurrent cases with negative nodes and recurrence-free cases with positive nodes in breast cancer Kawano, K.
 1998
 34 S5 p. S112-
1 p.
 artikel
124 Comparative study of fat suppressed MR imaging of breast cancer relative to mammography with microcalcification Kanasugi, K.
 1998
 34 S5 p. S76-S77
2 p.
 artikel
125 Comparative study of taxol (T) and Cisplatin © versus Taxotere (Tx) and vinorelbine (V) in metastatic breast cancer (MBC). Preliminary results Rodriguez, M.R.
 1998
 34 S5 p. S17-S18
2 p.
 artikel
126 Comparison of 3 versus 6 cycles CMF in node positive breast cancer patients based on 10 years follow-up Sauerbrei, W.
 1998
 34 S5 p. S41-
1 p.
 artikel
127 Computer aided diagnosis (CAD) in mammography Hendriks, J.H.
 1998
 34 S5 p. S5-
1 p.
 artikel
128 Concurrent paclitaxel and radiation in locally advanced Breast Cancer Formenti, C.
 1998
 34 S5 p. S12-
1 p.
 artikel
129 Conservation surgery and specialist treatment Kinqsmore, D.B.
 1998
 34 S5 p. S46-
1 p.
 artikel
130 Conservative surgery without radiation for the patients with the negative surgical margin of the early breast cancer — Significance of two stage treatment Kimura, M.
 1998
 34 S5 p. S52-
1 p.
 artikel
131 conservative treatment of stage II breast cancer patients with simultaneous mammoplastic operations Ostapenko, V.
 1998
 34 S5 p. S52-
1 p.
 artikel
132 Continuing education and results in breast cancer screening Rijken, H.
 1998
 34 S5 p. S93-
1 p.
 artikel
133 Continuous infusion of adriamycin + cyclophosphamide + 5-fluorouracil in disseminated breast cancer Karasyeva, V.
 1998
 34 S5 p. S16-
1 p.
 artikel
134 Contra: Genetic testing shouldnot be discouraged Klijn, J.G.M.
 1998
 34 S5 p. S87-
1 p.
 artikel
135 Correlation between sestamibi scintigraphy-mammography, mitochondria and neoangiogenesis in breast cancer Vanoli, C.
 1998
 34 S5 p. S80-
1 p.
 artikel
136 Cosmetic and functional sequelae related to breast cancer surgery Christiaens, M.R.
 1998
 34 S5 p. S6-
1 p.
 artikel
137 Cosmetic evaluation of breast conserving treatment for mammary cancer Niwin¯ska, Anna
 1998
 34 S5 p. S62-
1 p.
 artikel
138 Culture and communication: Approach to patients in clinical research Zwitter, Matjazˇ
 1998
 34 S5 p. S7-
1 p.
 artikel
139 Current trends in breast cancer Boyle, P.
 1998
 34 S5 p. S31-
1 p.
 artikel
140 Cytogenetic analysis of 112 breast tumors Penault-Llorca, F.
 1998
 34 S5 p. S117-
1 p.
 artikel
141 Danazol versus cabergolina for the treatment of cyclic mastalgia Gioffrè, W.
 1998
 34 S5 p. S126-
1 p.
 artikel
142 DCIS 3-D reconstruction. A new appraisal of retroareolar and nipple involvment Duval, C.
 1998
 34 S5 p. S9-
1 p.
 artikel
143 Depression as prognostic factor in breast cancer Jørgensen, T.
 1998
 34 S5 p. S106-
1 p.
 artikel
144 Depression subsequent to breast cancer Hjerl, K.
 1998
 34 S5 p. S120-
1 p.
 artikel
145 Detection by means of RT-PCR of micrometastases in the peripheral blood, bone marrow and leukapheresis products in women with breast cancer, selected for high-dose chemotherapy and peripheral blood progenitor cell transplantation Merla, G.
 1998
 34 S5 p. S73-
1 p.
 artikel
146 Determinants of prognosis after first isolated locoregional recurrence of breast cancer Schmoor, C.
 1998
 34 S5 p. S11-
1 p.
 artikel
147 Developing new methods of surgical management of breast cancer followed by plastic Esenkulov, A.E.
 1998
 34 S5 p. S29-
1 p.
 artikel
148 Developments in the palliation of metastatic bone disease Coleman, R.E.
 1998
 34 S5 p. S90-
1 p.
 artikel
149 Diagnostic problems of evaluating bone metastasis from breast cancer by proliferative activity: Comparison of findings between bone scintigraphy and MRI and their relationship to prognosis Nishimura, R.
 1998
 34 S5 p. S15-
1 p.
 artikel
150 Diagnostic significance of nipple discharge for detection of non-palpable breast cancer Yavoi, E.
 1998
 34 S5 p. S78-S79
2 p.
 artikel
151 Dietary factors and breast cancer Bingham, S.
 1998
 34 S5 p. S31-
1 p.
 artikel
152 Differential impact of high steroid hormone receptor concentrations on overall survival (OS) in primary breast cancer subgroups Struse, K.
 1998
 34 S5 p. S98-
1 p.
 artikel
153 Digital mammography and multimedial consultation in breast diagnosis Del Turco, M. Rosselli
 1998
 34 S5 p. S5-
1 p.
 artikel
154 DNA flow cytometry in breast carcinoma (BC): Comparison with clinical outcome Bogatyrev, V.N.
 1998
 34 S5 p. S109-
1 p.
 artikel
155 Docetaxel toxicity and activity in anthracycline-pretreated metastatic breast cancer (MBC) Milella, M.
 1998
 34 S5 p. S42-
1 p.
 artikel
156 Does prior pregnancy influence breast cancer outcome in young women? de la Rochefordière, A.
 1998
 34 S5 p. S98-
1 p.
 artikel
157 Does psychological response influence survival from breast cancer? Watson, M.
 1998
 34 S5 p. S120-
1 p.
 artikel
158 Does the administration of anthracyclines affect human tumour blood flow? Goodchild, K.
 1998
 34 S5 p. S45-
1 p.
 artikel
159 Do lobular & ductal carcinoma lead to different local recurrence rates after breast conservation? Chan, H.
 1998
 34 S5 p. S50-
1 p.
 artikel
160 Doppler ultrasound assessment of tumour response Robinson, T.M.
 1998
 34 S5 p. S76-
1 p.
 artikel
161 Dose-dense weekly docetaxel and CBDCA in adriamycin-resistant metastatic breast cancer (MBC) Salimi, Mehrdad
 1998
 34 S5 p. S44-
1 p.
 artikel
162 Doxorubicin (A) followed by docetaxel (T) versus doxorubicin + docetaxel (AT) in the adjuvant treatment of breast cancer (BC) Di Leo, A.
 1998
 34 S5 p. S41-
1 p.
 artikel
163 Doxorubicin vs CMF in the adjuvant tratment of high risk breast cancer Semiglazov, V.F.
 1998
 34 S5 p. S41-
1 p.
 artikel
164 Ductal carcinoma in situ: A revision of 43 cases Salicrú, S.
 1998
 34 S5 p. S10-
1 p.
 artikel
165 Ductal carcinoma in situ (DCIS): A comparison of three local treatments in current practice Cutuli, B.
 1998
 34 S5 p. S9-
1 p.
 artikel
166 Ductal carcinoma in situ: Factors affecting recurrence Hiew, L.Y.
 1998
 34 S5 p. S8-
1 p.
 artikel
167 Ductal carcinoma in situ of the breast: Is breast conserving treatment feasible? Yamakawa, T.
 1998
 34 S5 p. S9-S10
2 p.
 artikel
168 Dye-guided sentinel lymphadenectomy in clinically node-positive and node-negative breast cancer patients Noguchi, M.
 1998
 34 S5 p. S50-
1 p.
 artikel
169 Early breast cancer: How long should tamoxifen continue? Davies, C.
 1998
 34 S5 p. S43-S44
2 p.
 artikel
170 Early experience of ultraconservative skin saving mastectomy and immediate breast and areolar reconstruction Rainsbury, R.M.
 1998
 34 S5 p. S26-
1 p.
 artikel
171 Early treatment of metastatic breast cancer patients after increase of CEA and CA15-3 serum levels Krämer, S.
 1998
 34 S5 p. S42-
1 p.
 artikel
172 Effectiveness of mammographic screening for breast cancer in women aged over 50 years in Japan Morimoto, T.
 1998
 34 S5 p. S94-
1 p.
 artikel
173 Effect of dietary GLA +/− tamoxifen on growth and ER in a human breast cancer xenograft model Kennv, F.S.
 1998
 34 S5 p. S20-
1 p.
 artikel
174 Effect of radiotherapy in addition to 6 cycles CMF in node positive breast cancer patients Schmoor, C.
 1998
 34 S5 p. S59-
1 p.
 artikel
175 Efficacy and significance of sentinel lymph node identification with technetium-99m-labeled tin colloids for breast cancer Sato, K.
 1998
 34 S5 p. S50-
1 p.
 artikel
176 Efficiency of cytology for breast cancer without the evidence of malignancy on imaging diagnosis Koqa, T.
 1998
 34 S5 p. S74-
1 p.
 artikel
177 Efficiency of using the intensive regimen of chemotherapy with high doses of 5-fluorouracil in treating patients having breast cancer Slonimskava, E.M.
 1998
 34 S5 p. S22-
1 p.
 artikel
178 Elderly breast cancer in Chinese women Cheung, K.L.
 1998
 34 S5 p. S127-
1 p.
 artikel
179 Endocrine cell component in the breast carcinomas Akhova, O.M.
 1998
 34 S5 p. S77-
1 p.
 artikel
180 Endocrine therapy in breast cancer: A nurse education package Denton, S.
 1998
 34 S5 p. S65-
1 p.
 artikel
181 Endometrial changes caused by tamoxifen Ravter, Z.
 1998
 34 S5 p. S83-
1 p.
 artikel
182 EORTC 10941; Final results of a phase II study of liarozole fumarate in patients with metastatic breast cancer Klijn, J.
 1998
 34 S5 p. S18-
1 p.
 artikel
183 EORTC-IDBBC (Investigational Drug Branch for Breast Cancer): Seven years of active European collaboration Awada, A.
 1998
 34 S5 p. S21-
1 p.
 artikel
184 EORTC 10968; Phase I study of CaelyxTM at a six week interval in patients with metastatic breast cancer Hamilton, A.
 1998
 34 S5 p. S19-
1 p.
 artikel
185 EORTC randomised phase III trial 22922/10925 investigating the role of internal mammary chain (IMC) irradiation in stage I-III breast cancer: A quality assurance report on the dummy run Poortmans, Ph.
 1998
 34 S5 p. S58-
1 p.
 artikel
186 Epirubicina (EPI) and vinorelbine (VNR): High activity, dose dense regimen for primary breast cancer Nisticò, C.
 1998
 34 S5 p. S12-
1 p.
 artikel
187 Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study Redaelli, A.
 1998
 34 S5 p. S90-
1 p.
 artikel
188 Establishing a comprehensive hospital-based breast cancer support organisation Freilich, G.
 1998
 34 S5 p. S124-
1 p.
 artikel
189 Estrogen receptor analysis on breast cancer imprints Fallenius, G.
 1998
 34 S5 p. S115-
1 p.
 artikel
190 Estrogen receptor α and β expression in human breast cancer tissues analysed by RT-PCR Kobavashi, S.
 1998
 34 S5 p. S81-S82
2 p.
 artikel
191 Ethnicity, diet, and mammographic density patterns Maskarinec, G.
 1998
 34 S5 p. S23-
1 p.
 artikel
192 Europa Donna in Italy: Activities and goals Merzagora, Francesoa
 1998
 34 S5 p. S64-S65
2 p.
 artikel
193 Europa Donna Italian Forum: Results of a survey among the breast cancer associations Mosconi, Paola
 1998
 34 S5 p. S67-
1 p.
 artikel
194 Evaluation of acute local toxicity after postoperative 60 gy to the whole breast in multifocal invasive or in situ ductal breast carcinoma Valli, M.C.
 1998
 34 S5 p. S61-
1 p.
 artikel
195 Evaluation of biological prognostic factors in relation to local recurrence after breast conserving therapy Gelder, M.E. Meijer-van
 1998
 34 S5 p. S97-
1 p.
 artikel
196 Expanding our knowledge of breast cancer biology: Will it impact on patient management? Piccart, Martine J.
 1998
 34 S5 p. S39-
1 p.
 artikel
197 Experimental pathology and breast cancer genetics: Looking at malignant and premalignant tissues using new technologies Osin, P.
 1998
 34 S5 p. S96-
1 p.
 artikel
198 Expression of cytosolic thymidine kinase in the proliferative breast carcinoma after primary chemotherapy: Therapeutic indication Gachon, F.
 1998
 34 S5 p. S103-
1 p.
 artikel
199 Expression of S100-α and S100-β in atypical papilloma, atypical papillomatosis and atypical intraductal hyperplasia of the breast Ichihara, S.
 1998
 34 S5 p. S113-
1 p.
 artikel
200 Expression of tenascin-C in intraductal carcinoma of human breast: Relation to invasion Jahkola, Tiina
 1998
 34 S5 p. S9-
1 p.
 artikel
201 Expression of the apoptosis-related genesc-myc,p53 andbcl2 in breast carcinomas from operable patients. Onlybcl2 expression is associated with a lower risk of death Riou, G.
 1998
 34 S5 p. S98-S99
2 p.
 artikel
202 Expression of the c-erbB-4/her-4 growth factor receptor in breast cancer Gullick, W.J.
 1998
 34 S5 p. S37-
1 p.
 artikel
203 Factors influencing women's decisions to undergo genetic testing for breast cancer Cappelli, M.
 1998
 34 S5 p. S94-
1 p.
 artikel
204 Facts and figures from the meta-analyses in breast cancer Peto, R.
 1998
 34 S5 p. S88-
1 p.
 artikel
205 Familiar history in breast conservative treatment of breast cancer a good prognostic factor? Jobsen, Jan J.
 1998
 34 S5 p. S98-
1 p.
 artikel
206 Family history of breast cancer and local recurrence after breast conserving therapy Brekelmans, C.T.M.
 1998
 34 S5 p. S12-
1 p.
 artikel
207 FDG-PET in breast cancer staging and biological characterization Bombardieri, E.
 1998
 34 S5 p. S36-
1 p.
 artikel
208 Final results of a phase II study of Taxotere (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in thétreatment of metastatic breast cancer (MBC) Nabholtz, J.-M.
 1998
 34 S5 p. S43-
1 p.
 artikel
209 Fine needle aspiration cytology (FNAC) vs core biopsy Svane, G.
 1998
 34 S5 p. S4-
1 p.
 artikel
210 First-degree family history and breast cancer de Souza, R.M.
 1998
 34 S5 p. S25-
1 p.
 artikel
211 First interim results of an ongoing study comparing the GNRH-agonist leuprorelinacetate and CMF as adjuvant treatment in premenopausal breast cancer Untch, M.
 1998
 34 S5 p. S20-
1 p.
 artikel
212 Flap recurrence following mastectomy for breast cancer: local failure or systemic disease Byrne, G.J.
 1998
 34 S5 p. S11-
1 p.
 artikel
213 FNA to core biopsy — A need for change? Flanagan, F.
 1998
 34 S5 p. S72-
1 p.
 artikel
214 Full length analysis of BRCA1 gene in sporadic breast cancer: Detection of common haplotypes and a novel possibly somatic mutation affecting gene translation Papa, S.
 1998
 34 S5 p. S77-
1 p.
 artikel
215 Full thickness resection of chestwall for local recurrence of breast cancer Tjalma, W.
 1998
 34 S5 p. S29-
1 p.
 artikel
216 Functional and cosmetic results in breast preserving treatment (BPT) Prekaiski, M.
 1998
 34 S5 p. S55-S56
2 p.
 artikel
217 Functional intravital assay of anticancer drug efflux transporters in breast cancer biopsy specimens Bogush, T.
 1998
 34 S5 p. S106-
1 p.
 artikel
218 Gamma linolenic acid with tamoxifen as primary therapy in breast cancer Kenny, F.S.
 1998
 34 S5 p. S18-S19
2 p.
 artikel
219 Genetic counseling: The reality of the Italian associations against breast cancer Monesi, Lalla
 1998
 34 S5 p. S68-
1 p.
 artikel
220 Genetic testing and its impact on a cohort of women and their families Ormiston, W.J.
 1998
 34 S5 p. S84-
1 p.
 artikel
221 Geographic distribution within the Netherlands of families with specific mutations in EIRCA1 and BRCA2 Verhoog, L
 1998
 34 S5 p. S23-
1 p.
 artikel
222 Heregulin and doxorubicin activate a p53 dependent pathway in cancer cells whereas taxol depends on activation of the MAP kinase pathway Bacus, S.
 1998
 34 S5 p. S30-
1 p.
 artikel
223 HER-2/neu oncogene amplification in breast cancer Brien, T.P.
 1998
 34 S5 p. S103-S104
2 p.
 artikel
224 High-dose chemotherapy with peripheral blood stem cell transplantation as adjuvant therapy for primary breast cancer Iwase, K.
 1998
 34 S5 p. S14-
1 p.
 artikel
225 H igh resolution computed tomography imaging is useful for the detection of the intraductal tumor spread in breast cancer Kobavashi, N.
 1998
 34 S5 p. S72-S73
2 p.
 artikel
226 Histiocytoid breast carcinoma: Histopathological study and a proposal of the diagnostic criteria Shimizu, S.
 1998
 34 S5 p. S113-
1 p.
 artikel
227 Histopathologic basis for axillary sampling Csemi, G.
 1998
 34 S5 p. S109-
1 p.
 artikel
228 Hormone replacement therapy does not influence pathological stage of breast cancer in 1113 tumours Stallard, S.
 1998
 34 S5 p. S82-
1 p.
 artikel
229 Hormonotherapy with goserelin depot after adjuvant chemotherapy in premenopausal women with early breast cancer: Is there any benefit? De Matteis, A.
 1998
 34 S5 p. S44-
1 p.
 artikel
230 How can survival for women in Scotland with breast cancer be improved? Twelves, J.C.
 1998
 34 S5 p. S64-
1 p.
 artikel
231 How can women affect health policy Tonge, Jenny
 1998
 34 S5 p. S7-
1 p.
 artikel
232 11β-hydroxysteroid dehydrogenase activity in human breast cancer cells: Characterization and effect of hormonal manipulations Arcuri, F.
 1998
 34 S5 p. S84-
1 p.
 artikel
233 ICAM-1 up-regulation expression on breast cancer cell lines after all-trans retinoic acid (ATRA) treatment is independent of hormonal receptor conditions Baj, G.
 1998
 34 S5 p. S116-
1 p.
 artikel
234 Identification of recurrent breast cancer with radiolabelled isonitriles Buscombe, J.R.
 1998
 34 S5 p. S11-
1 p.
 artikel
235 Idoxifene antagonism of oestradiol-dependent MCF-7 breast cancer xenograft growth Johnston, S.R.D.
 1998
 34 S5 p. S81-
1 p.
 artikel
236 Image analysis of imprint cytology from invasive breast carcinoma and its relation to axillary node metastasis Idvall, I.
 1998
 34 S5 p. S114-
1 p.
 artikel
237 Immediate breast reconstruction in breast cancer Demidov, V.P.
 1998
 34 S5 p. S29-
1 p.
 artikel
238 Immediate reconstruction in breast cancer surgery. Three hundred consecutive cases using prostheses and flaps Montanari, M.
 1998
 34 S5 p. S26-
1 p.
 artikel
239 Implications of social support for survivors of breast cancer Gorin, S. Sheinfeld
 1998
 34 S5 p. S122-
1 p.
 artikel
240 Importance of tissue-infiltrating macrophage activation in breast cancer progression Toi, M.
 1998
 34 S5 p. S97-
1 p.
 artikel
241 Improvements in survival from the NHS mammographic screening programme — A single centre study Chan, H.
 1998
 34 S5 p. S94-S95
2 p.
 artikel
242 Improving results in the treatment of locally advanced T4 breast cancer Ionta, M.T.
 1998
 34 S5 p. S16-
1 p.
 artikel
243 Inactivation of E-cadherin in breast cancer Van de Vijver, M.J.
 1998
 34 S5 p. S37-
1 p.
 artikel
244 Incidence of breast cancer associated with use of hormone replacement therapy and other risk factors in 1709 patients Gehani, S.
 1998
 34 S5 p. S118-
1 p.
 artikel
245 Increased risk of recurrence for patients with EGFR and HER-p185 positive tumours; when treated adjuvantly with tamoxifen for one year Knoo, A.
 1998
 34 S5 p. S81-
1 p.
 artikel
246 Increased risk of tumor recurrence following breast conserving therapy (BCT) in hereditary breast cancer as compared with sporadic breast cancer (BC) Sevnaeve, C.
 1998
 34 S5 p. S47-
1 p.
 artikel
247 Increasing the percentage of breast-conserving surgery for treatment of breast cancer Escobedo, A.
 1998
 34 S5 p. S55-
1 p.
 artikel
248 Independent role of p53 expression and reduction in kinetic cell activity in predicting clinical complete response (CR) to primary chemotherapy in breast cancer (BC) patients Bottini, A.
 1998
 34 S5 p. S102-
1 p.
 artikel
249 (111Indium-DTPA-D-Phe) octreotide scintigraphy in the diagnostic assessment of palpable breast lumps Parker, S.J.
 1998
 34 S5 p. S74-
1 p.
 artikel
250 Individual breast cancer risk assessement in postmenopausal women de Souza, R.M.
 1998
 34 S5 p. S24-S25
2 p.
 artikel
251 Individual breast cancer risk in premenopausal women de Souza, R.M.
 1998
 34 S5 p. S24-
1 p.
 artikel
252 Induction of PCD with doxorubicin in invasive lobular carcinoma cells of human breast by circumventing MDR-1 with colloidal phosphorothioate Giannios, J.
 1998
 34 S5 p. S120-
1 p.
 artikel
253 Influence of amifostine (A) on the toxicity and pharmacokinetics (PK) of docetaxel (D) in breast cancer patients: An EORTC-IDBBC study de Valeriola, D.
 1998
 34 S5 p. S19-
1 p.
 artikel
254 Inherited predispostion to breast cancer Daly, P.A.
 1998
 34 S5 p. S84-
1 p.
 artikel
255 Inherited susceptibility to breast cancer: A psychological perspective Cull, Ann
 1998
 34 S5 p. S84-
1 p.
 artikel
256 In situ trap method for the cytological examination of breast cancer (preliminary report) Nakavama, S.
 1998
 34 S5 p. S80-S81
2 p.
 artikel
257 In situ trap method for the histological examination of breast cancer (preliminary report) Kaise, H.
 1998
 34 S5 p. S78-
1 p.
 artikel
258 Intraocular metastases from breast cancer: A retrospective Study of the Breast Cancer North Italian Radiation Therapy Oncology Group Amichetti, M.
 1998
 34 S5 p. S60-S61
2 p.
 artikel
259 Intratumoral beta-radiometry is an universal test of breast cancer (BC) activity Portnoi, S.M.
 1998
 34 S5 p. S110-
1 p.
 artikel
260 Intratumoral fluorouracil (5-FU) injectable gel as a potentiator of standard radiotherapy in patients with locally recurrent or advanced breast cancer Kuske, R.
 1998
 34 S5 p. S60-
1 p.
 artikel
261 Intratumoral focused chemotherapy with cisplatin/ epinephrine injectable gel for palliative treatment of metastatic breast cancer Fernando, I.
 1998
 34 S5 p. S21-
1 p.
 artikel
262 Intratumoral therapy with VRCTC-310 for refractory skin metastatic breast cancer. Preliminary report Costa, L.
 1998
 34 S5 p. S22-
1 p.
 artikel
263 Introduction to cancer clinical trials Therasse, P.
 1998
 34 S5 p. S128-
1 p.
 artikel
264 Investigation of local blood flow in breast cancer by colour Doppter ultrasonography and immunohistochemistry Jimbo, S.
 1998
 34 S5 p. S75-
1 p.
 artikel
265 In vivo bromodeoxyuridine (BrdUrd) labeling index as a prognostic marker in human breast cancer Goodson, W.H.
 1998
 34 S5 p. S103-
1 p.
 artikel
266 Is annual mammography better to detect a contralateral breast cancer than mammography at a greater interval? Kaas, R.
 1998
 34 S5 p. S93-
1 p.
 artikel
267 Is hypofractionated breast radiotherapy a valid treatment option? Ryan, G.
 1998
 34 S5 p. S58-
1 p.
 artikel
268 Is it necessary to check blood counts routinely during definitive radiation therapy for patients with early stage breast cancer? Erdmann-Elbinqer, B.
 1998
 34 S5 p. S61-
1 p.
 artikel
269 Isolated local-regional recurrence of breast cancer: Impact of rediatherapy on dissemination and survival Kambv, C.
 1998
 34 S5 p. S11-
1 p.
 artikel
270 Isssues around informed consent — Why and when should women participate in clinical trials? Goodare, H.
 1998
 34 S5 p. S128-
1 p.
 artikel
271 Is the timing of radiotherapy after breast conservation surgery for early stage cancer important? Ampil, F.
 1998
 34 S5 p. S61-S62
2 p.
 artikel
272 Knowledge and beliefs about breast cancer prevention in an unselected female Italian population Biamonte, R.
 1998
 34 S5 p. S66-
1 p.
 artikel
273 Lack of correlation betweenc-erbB-2 overexpression and the effect of dose-intensification of adjuvant chemotherapy in high-risk breast cancer patients Thomssen, C.
 1998
 34 S5 p. S30-
1 p.
 artikel
274 Late psychological sequelae of breast cancer Maguire, Peter
 1998
 34 S5 p. S6-
1 p.
 artikel
275 Late sequelae of breast cancer treatment: systematic therapy Rose, C.
 1998
 34 S5 p. S5-S6
2 p.
 artikel
276 Late sequelae of radiotherapy in breast cancer Jassem, J.
 1998
 34 S5 p. S6-
1 p.
 artikel
277 Letrozole as primary medical therapy for locally advanced and large operable breast cancer Dixon, J.M.
 1998
 34 S5 p. S13-
1 p.
 artikel
278 Liver metastases from breast cancer — Clinical feature and treatment Masuda, N.
 1998
 34 S5 p. S18-
1 p.
 artikel
279 Locally advanced and metastatic breast cancer Rubens, R.D.
 1998
 34 S5 p. S10-
1 p.
 artikel
280 Local recurrence in women with ductal carcinoma in situ (DCIS) according to the treatment Limite, G.
 1998
 34 S5 p. S10-
1 p.
 artikel
281 Local recurrence (LR) after breast-conserving therapy (BCT) in node-negative premenopausal patients: Influence of perloperative chemotherapy (PeCT) Elkhuizen, P.H.M.
 1998
 34 S5 p. S101-
1 p.
 artikel
282 Loco-regional recurrence in randomized trial of breast cancer TNM stage II. Prognostic factors Tennvall-Nittby, L.
 1998
 34 S5 p. S106-
1 p.
 artikel
283 Long duration of response with letrozole 2.5 mg (Femara®) in two trials in postmenopausal women with advanced breast cancer after anti-estrogen therapy Gardin, G.
 1998
 34 S5 p. S13-S14
2 p.
 artikel
284 Long term cosmetic results of immediate breast reconstruction by implants Vlastos, G.
 1998
 34 S5 p. S27-
1 p.
 artikel
285 Long-term follow-up of the first breast conservation trial (Guy's Wide Excision Study) Fentiman, Ian S.
 1998
 34 S5 p. S37-S38
2 p.
 artikel
286 Long term survival in elderly breast cancer patients treated with tamoxifen (TAM) alone vs surgery followed by TAM Thomas, R.
 1998
 34 S5 p. S126-
1 p.
 artikel
287 Long term survival of patients treated with neoadjuvant chemotherapy for operable breast tumors: Results of a randomized trial with a 10 year-follow-up Mauriac, L.
 1998
 34 S5 p. S40-
1 p.
 artikel
288 Long-term (5–10 year) results of combined treatment of breast cancer patients using gamma-neutron therapy Smimova, I.
 1998
 34 S5 p. S61-
1 p.
 artikel
289 Loss of heterozygosity (LOH) and allelic imbalance (AI) in apocrine metaplasia and apocrine adenosis of the breast Selim, S.
 1998
 34 S5 p. S111-
1 p.
 artikel
290 Loss of heterozygosity (LOH) in normal epithelial and myoepithelial cells from tissues adjacent to breast carcinoma Odell, C.
 1998
 34 S5 p. S111-
1 p.
 artikel
291 ‘Lunate flaps’: Tissue advancement for parenchymal reconstruction in breast cancer surgery Baildam, A.D.
 1998
 34 S5 p. S53-
1 p.
 artikel
292 Lymphatic mapping and sentinel lymphadenectomy Giuliano, A.E.
 1998
 34 S5 p. S36-
1 p.
 artikel
293 Lymphocyte subgroups in breast cancer and the effect of tumor removal Balaban, F.
 1998
 34 S5 p. S107-
1 p.
 artikel
294 Magnetic resonance guided breast surgery Vauqhan, N.
 1998
 34 S5 p. S48-
1 p.
 artikel
295 Male breast cancer: A retrospective analysis of patients treated in Trieste, Italy Sandri, P.
 1998
 34 S5 p. S51-
1 p.
 artikel
296 Male breast cancer: A 20 year review of 60 patients in Slovenia Juzˇnicˇ, T.
 1998
 34 S5 p. S108-
1 p.
 artikel
297 Mammary mucin secretion: A modern revisitation and review Davies, J.D.
 1998
 34 S5 p. S110-S111
2 p.
 artikel
298 Mammographic parenchymal, patterns and breast histology Bayar, S.
 1998
 34 S5 p. S79-
1 p.
 artikel
299 Mammographic-pathologic correlations Holland, R.
 1998
 34 S5 p. S4-
1 p.
 artikel
300 Mammography screening in Norway. Is it cost effective? Norum, J.
 1998
 34 S5 p. S92-
1 p.
 artikel
301 Management of non-palpable mammographic abnormalities: ABBI excision vs core biopsy Menon, M.
 1998
 34 S5 p. S48-
1 p.
 artikel
302 Management of palpable asymmetrical thickening of the breast Cheung, K.L.
 1998
 34 S5 p. S79-
1 p.
 artikel
303 Mass-screening for breast cancer in Japan Fujishima, N.
 1998
 34 S5 p. S95-
1 p.
 artikel
304 Mastectomy in addition to chemotheraphy improves relapse free survival in women with localy advanced breast cancer Bajic, N.
 1998
 34 S5 p. S16-
1 p.
 artikel
305 Medullary breast carcinoma. Ten-year results in 108 patients treated in a single center Dendale, R.
 1998
 34 S5 p. S99-
1 p.
 artikel
306 Menstrual phase and timing of breast cancer surgery: Statistical aspects Haeusler, G.
 1998
 34 S5 p. S102-S103
2 p.
 artikel
307 Meta-analysis of dose intensity in breast cancer neoadjuvant chemotherapy (1997 update) Shparvk, Y.
 1998
 34 S5 p. S43-
1 p.
 artikel
308 Microinvasive carcinoma of the breast: Is axillary lymph node dissection indicated? Penault-Llorca, F.
 1998
 34 S5 p. S49-
1 p.
 artikel
309 Mitomycin (M), epirubicin (E) and vinorelbine (V) first-line chemotherapy for metastatic breast cancer (MBC). A feasibility study Neri, Alessandro
 1998
 34 S5 p. S44-
1 p.
 artikel
310 Molecular mechanisms leading to C-ERBB2 gene overexpression in breast cancers Winkler, M.
 1998
 34 S5 p. S115-S116
2 p.
 artikel
311 Morbidity following immediate breast reconstruction (IBR) after mastectomy Venizelos, B.
 1998
 34 S5 p. S27-
1 p.
 artikel
312 “Morbidity of quadrantectomy vs mastectomy in operable breast cancer” Nieto, A.
 1998
 34 S5 p. S55-
1 p.
 artikel
313 Morphological and clinical characteristics of patients with ipsilateral recurrence after DCIS Ringberg, A.
 1998
 34 S5 p. S9-
1 p.
 artikel
314 MR imaging in the preoperative staging of breast carcinoma: Useful or riskful? Van Goethem, M.
 1998
 34 S5 p. S70-
1 p.
 artikel
315 MR imaging of the breast in patients with mammographically ill-defined breast cancer Sawai, Y.
 1998
 34 S5 p. S73-
1 p.
 artikel
316 mRNA determination of estrigen receptor, progestin receptor, pS2. PAI-1 by competitive reverse transcrlption-PCR in human breast cancer Tong, Dan
 1998
 34 S5 p. S99-
1 p.
 artikel
317 99mTc-MIBI breast scintigraphy using a dedicated nuclear mammograph Semprebene, A.
 1998
 34 S5 p. S73-S74
2 p.
 artikel
318 99mTc-MIBI scintigraphy evaluates response to neoadjuvant chemotherapy in locally advanced breast cancer Festa, A.
 1998
 34 S5 p. S10-S11
2 p.
 artikel
319 99mTc-MIBI scintimammography (SM) in 300 patients with breast masses: Correlation with tumor proliferative activity Pasqualoni, R.
 1998
 34 S5 p. S69-
1 p.
 artikel
320 99mTc-scintimammography in the diagnosis of non-palpable breast lesions in relation to the mammographical probabilities of malignancy and microcalcifications Carril, J.M.
 1998
 34 S5 p. S69-
1 p.
 artikel
321 Multifocality in intraductal carcinoma of breast in young Chinese Yu, J.C.
 1998
 34 S5 p. S54-
1 p.
 artikel
322 Multiple lymphatic drainage pathways in breast cancer and its implication for sentinel lymph node (SLN) biopsy and internal mammary (IM) lymph node biopsy or radiation Jadvar, S. Jeffrey
 1998
 34 S5 p. S51-
1 p.
 artikel
323 Multisite phosphotyping of the ErbB2 oncoprotein in 102 human breast cancers Ouyang, X.
 1998
 34 S5 p. S116-
1 p.
 artikel
324 Multivariate analysis of prognostic factors in lymph node negative breast cancer Ross, J.S.
 1998
 34 S5 p. S102-
1 p.
 artikel
325 Mutations in the BRCA1 and BRCA2 genes: Uptake of presymptomatic DMA test, preventive choices and breast cancer risk after prophylactic mastectomy Meijers-Heijboer, Hanne
 1998
 34 S5 p. S23-
1 p.
 artikel
326 Mutations in the p53 gene, both within and outside the zinc-binding domains, are associated with increased apoptosis and mitosis in invasive breast carcinomas van Slooten, H.-J.
 1998
 34 S5 p. S116-
1 p.
 artikel
327 National survey of women with breast cancer in Australia Redman, S.
 1998
 34 S5 p. S63-
1 p.
 artikel
328 Needle localization breast biopsy for nonpalpable breast lesions Nagadowska, Monika
 1998
 34 S5 p. S79-
1 p.
 artikel
329 Needs for care in breast cancer patients de Haes, J.C.J.M.
 1998
 34 S5 p. S39-
1 p.
 artikel
330 Neo-adjuvant chemo-radiotherapy for operable breast cancer. Preliminary results of an ongoing phase II study Pacini, P.
 1998
 34 S5 p. S59-
1 p.
 artikel
331 Neoadjuvant chemotherapy for primary breast cancer — How many breasts are saved? Bramley, M.D.
 1998
 34 S5 p. S53-
1 p.
 artikel
332 Neoadjuvant hormonal therapy in locally advanced breast cancer da Silva, J.M. Leal
 1998
 34 S5 p. S15-
1 p.
 artikel
333 Neu differentiation factor (NDF/heregulin) induces expression of adhesion molecules, increased cellular invasiveness, and is expressed in Paget's disease of the breast together with its receptors Bacus, S.
 1998
 34 S5 p. S116-
1 p.
 artikel
334 Neural networks improve the prediction of survival in breast cancer Drew, P.J.
 1998
 34 S5 p. S100-
1 p.
 artikel
335 New challenges in the medical treatment of breast cancer Gianni, L
 1998
 34 S5 p. S40-
1 p.
 artikel
336 New drugs in breast cancer Mauriac, L.
 1998
 34 S5 p. S18-
1 p.
 artikel
337 New era of treatment in breast cancer — Neoadjuvant therapy without surgery Bretz, P.D.
 1998
 34 S5 p. S107-
1 p.
 artikel
338 New perspectives on screening, quality assurance and prevention 1998
 34 S5 p. S68-
1 p.
 artikel
339 Nine years results of breast carcinoma conservative treatment for 295pTI≤ 10mm N— without adjuvant medical treatment Héry, M.
 1998
 34 S5 p. S61-
1 p.
 artikel
340 Nipple discharge correlation between: clinic, radiology and histology Sabadell, D.
 1998
 34 S5 p. S77-
1 p.
 artikel
341 Non-invasive follow-up of the viscoelasticity of the breast skin following radiation therapy Gorodetskv, R.
 1998
 34 S5 p. S59-
1 p.
 artikel
342 Non-palpable breast lesions Sandrini, R.
 1998
 34 S5 p. S56-
1 p.
 artikel
343 NSABP Protocol B-06: A randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer — Results after 15 years of follow-up Wickerham, D.L.
 1998
 34 S5 p. S38-
1 p.
 artikel
344 Nuclear abnormalities (nuclear pockets) in apocrine breast carcinoma: Report of a case Stravoravdi, P.
 1998
 34 S5 p. S114-
1 p.
 artikel
345 Nuclear magnetic resonance and breast cancer diagnosis Kaiser, W.A.
 1998
 34 S5 p. S5-
1 p.
 artikel
346 Nurses' role in breast cancer control in a multinational community Thomas, R.
 1998
 34 S5 p. S65-S66
2 p.
 artikel
347 Ocular toxicity from standard dose adjuvant tamoxifen therapy Dulley, P.
 1998
 34 S5 p. S81-
1 p.
 artikel
348 Ocular toxicity related to tamoxifen therapy Veselinović, S.
 1998
 34 S5 p. S45-
1 p.
 artikel
349 Oncologic outcome in patients with breast cancer treated with breast conserving reconstruction Noguchi, M.
 1998
 34 S5 p. S49-
1 p.
 artikel
350 Onco-plastic concept (tumor specific immediate reconstruction — TSIR) in breast cancer surgery Crnogorac, M.
 1998
 34 S5 p. S28-
1 p.
 artikel
351 On the way towards integration: A psycho-educational group for breast cancer patients Levsen, B.
 1998
 34 S5 p. S122-
1 p.
 artikel
352 Optimal follow-up after primary treatment Ciatto, Stefano
 1998
 34 S5 p. S89-
1 p.
 artikel
353 Outcome in patients with advanced breast cancer treated with anastrozole following loss of reponse to tamoxifen and megestrol acetate Mihaimeed, F.
 1998
 34 S5 p. S22-
1 p.
 artikel
354 Ovarian hormones effect VEGF expression in breast cancer cells Heer, K.
 1998
 34 S5 p. S117-
1 p.
 artikel
355 Ovarian toxicity of breast cancer chemotherapy Weber, B.
 1998
 34 S5 p. S42-
1 p.
 artikel
356 Palpable breast tumors: Preoperative determination of histology and receptor status Cerwenka, H.
 1998
 34 S5 p. S70-
1 p.
 artikel
357 Parcours de femmes: A survey of opinions of French women with cancer; the first step of a pan-European survey in 16 countries Serin, D.
 1998
 34 S5 p. S62-
1 p.
 artikel
358 Patient evaluation of hormone therapy in breast cancer: Quantifying trade-offs between survival gains and quality of life Fellowes, D.
 1998
 34 S5 p. S122-
1 p.
 artikel
359 Patients' perceptions of routine follow-up after treatment for breast cancer and nurse-led clinics Pennery, E.
 1998
 34 S5 p. S66-
1 p.
 artikel
360 Performance issues in detection and diagnosis Perry, Nick
 1998
 34 S5 p. S68-
1 p.
 artikel
361 p43 expression on lymphocytes — A marker for early breast cancer in patients with nonpalpable mammographic finding Auerbach, L.
 1998
 34 S5 p. S74-
1 p.
 artikel
362 p-Glycoprotein (pGP) and p53 expression in primary breast cancer Betta, P.G.
 1998
 34 S5 p. S119-S120
2 p.
 artikel
363 Phase III trial comparing epirubicin/paclitaxel vs epirubicin/cyclophosphamid as first line treatment in metastatic breast cancer: Preliminary results of a German AGO trial von Minckwitz, G.
 1998
 34 S5 p. S90-
1 p.
 artikel
364 Photodynamic therapy versus laser induced thermotherapy in the treatment of local recurrences and skin secondaries of breast cancer Ismail, M.S.
 1998
 34 S5 p. S15-
1 p.
 artikel
365 Plasma thrombospondin (pTSP) in early and advanced breast cancer Byrne, G.J.
 1998
 34 S5 p. S19-S20
2 p.
 artikel
366 Plastic procedures in conservative surgery for breast cancer Caruso, F.
 1998
 34 S5 p. S54-
1 p.
 artikel
367 Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in breast cancer Nagaoka, H.
 1998
 34 S5 p. S101-S102
2 p.
 artikel
368 Power doppler vascularity in malignant breast tumours: Correlation with pathological blood vessel counts, microvessel density and other histopathological prognostic factors The, W.L
 1998
 34 S5 p. S112-
1 p.
 artikel
369 Predicting nodal status in patients with T1 breast cancer Harden, S.P.
 1998
 34 S5 p. S47-
1 p.
 artikel
370 Predicting the prognosis of breast carcinoma — What the pathologist should do? Kulka, J.
 1998
 34 S5 p. S114-
1 p.
 artikel
371 Prediction of axillary lymphatic node status in primary breast cancer — Comparison between positron emission tomography (PET) and sentinel-node biopsy Santiohanser, C.
 1998
 34 S5 p. S71-
1 p.
 artikel
372 Predictive factors of response to neo-adjuvant chemotherapy by immunohistochemistry (IHC) Mac Grogan, G.
 1998
 34 S5 p. S111-S112
2 p.
 artikel
373 Predictive value of vascular endothelial growth factor (VEGF) for overall survival in estrogen receptor positive breast carcinoma Linderholm, B.
 1998
 34 S5 p. S97-
1 p.
 artikel
374 Predictors of axillary lymph node metastases van de Vijver, M.J.
 1998
 34 S5 p. S36-
1 p.
 artikel
375 Predictors of emotional well-being and quality of life in women with primary breast cancer Vos, P.J.
 1998
 34 S5 p. S124-
1 p.
 artikel
376 Preliminary psychometric testing of a comprehensive assessment of satisfaction with care in an oncology institute Brédart, A.
 1998
 34 S5 p. S6-S7
2 p.
 artikel
377 Preliminary results in the scintigraphic and radiosurgical identification of sentinel node (SN) in early stage breast cancer Feggi, L.
 1998
 34 S5 p. S80-
1 p.
 artikel
378 Preoperative assessment of axillary lymph-node involvement in small breast cancers. Analysis of 893 cases Cululi, B.
 1998
 34 S5 p. S46-
1 p.
 artikel
379 Pre-operative detection of breast cancer multicentricity with MRI Douek, M.
 1998
 34 S5 p. S71-
1 p.
 artikel
380 Pre-operative diagnosis of screen detected cancers: Increasing the diagnostic rate Bradpiece, H.A.
 1998
 34 S5 p. S94-
1 p.
 artikel
381 Preoperative factors influencing complete excision of palpable breast cancer in breast conserving therapy Venizelos, B.
 1998
 34 S5 p. S50-
1 p.
 artikel
382 Preoperative identification of node negative axillary lymph nodes in breast cancer by highly significant electron beam computertomography (EBG) Smola, M.G.
 1998
 34 S5 p. S69-
1 p.
 artikel
383 Preoperative MRI does not influence the amount of breast tissue excised in conservative cancer surgery Douek, M.
 1998
 34 S5 p. S45-S46
2 p.
 artikel
384 Preoperative serum VEGF in primary breast cancer patients — Its relation with oestrogen receptor status and cancer type Heer, K.
 1998
 34 S5 p. S29-
1 p.
 artikel
385 Presurgery chemotherapy and DNA ploidy of the adenocarcinoma breast cells Nikolaeva, T.
 1998
 34 S5 p. S119-
1 p.
 artikel
386 Presymptomatic testing for hereditary breast/ovarian cancer (HBOC): Is there psychological distress in the pre-test period? Lodder, L.N.
 1998
 34 S5 p. S123-
1 p.
 artikel
387 Primary chemotherapy for locally advanced breast cancer using film as a novel regimen Davidson, N.
 1998
 34 S5 p. S13-
1 p.
 artikel
388 Primary medical treatment of locally advanced disease reveals causes of failure of adjuvant chemotherapy Johnson, Ann
 1998
 34 S5 p. S17-
1 p.
 artikel
389 Primary paclitaxel in breast cancer: Is beta-tubulin a predictor for pathological response? Formenti, C.
 1998
 34 S5 p. S117-S118
2 p.
 artikel
390 Pro: Genetic testing should be discouraged Baum, Michael
 1998
 34 S5 p. S87-
1 p.
 artikel
391 Prognosis of 56 male breast cancers — Comparison with females Herman, K.
 1998
 34 S5 p. S105-S106
2 p.
 artikel
392 Prognosis of the typical medullary carcinoma of the breast Stelmach, A.
 1998
 34 S5 p. S110-
1 p.
 artikel
393 Prognosticators in axillary node negative breast cancer Fiets, W.E.
 1998
 34 S5 p. S106-
1 p.
 artikel
394 Prognostic factors in human breast cancer Storace, A.
 1998
 34 S5 p. S104-
1 p.
 artikel
395 Prognostic factors in patients with recurrent breast cancer following mastectomy Icli, F.
 1998
 34 S5 p. S109-
1 p.
 artikel
396 Prognostic impact of HER-2/neu gene copy number determination by fluorescence in situ hybridisation (FISH) versus immunohistochemically detected overexpression in node positive primary breast cancer Bojar, H.
 1998
 34 S5 p. S30-
1 p.
 artikel
397 Prognostic importance of active thermography in breast cancer Mazurin, V.
 1998
 34 S5 p. S108-S109
2 p.
 artikel
398 Prognostic markers in neoadjuvent chemotherapy Green, L
 1998
 34 S5 p. S107-S108
2 p.
 artikel
399 Prognostic significance of keratins in breast cancer Grabau, A.D.
 1998
 34 S5 p. S100-
1 p.
 artikel
400 Prognostic significance of p53 mutations in the zinc-binding domains (L2/L3) in lymph node-positive breast cancer patients Kucera, E.
 1998
 34 S5 p. S99-
1 p.
 artikel
401 Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer Kainz, Ch.
 1998
 34 S5 p. S20-S21
2 p.
 artikel
402 Proliferation, apoptosis and related markers in invasive ductal breast carcinoma Buytaert, P.
 1998
 34 S5 p. S118-
1 p.
 artikel
403 Promoting healthy women Lewis, M.
 1998
 34 S5 p. S66-S67
2 p.
 artikel
404 Prophylactic mastectomy: Patient selection and development of a surgical technique Baildam, A.D.
 1998
 34 S5 p. S49-
1 p.
 artikel
405 Prospective randomized study on drainages removal timing in breast cancer surgery Amanti, C.
 1998
 34 S5 p. S53-
1 p.
 artikel
406 Proteolytic enzymes in prevention an treatment of lymphatic oedema of arm after axillary dissection or radiotherapy Machán˛ova, M.
 1998
 34 S5 p. S125-S126
2 p.
 artikel
407 PS2 helps to predict responders to tamoxifen therapy in patients with recurrent breast cancer Look, M.P.
 1998
 34 S5 p. S31-
1 p.
 artikel
408 Psychological and clinical quality of life determinants among women with breath cancer in different stages Zwaligski, M.
 1998
 34 S5 p. S125-
1 p.
 artikel
409 Psychological factors in the use of complementary therapies Steele, Sandra
 1998
 34 S5 p. S31-
1 p.
 artikel
410 Psychological impact of genetic counselling and testing on women at high risk of developing breast cancer: Preliminary findings Meiser, B.
 1998
 34 S5 p. S123-
1 p.
 artikel
411 Psychosocial compliance and response rates in a chemoprevention randomised control trial of women at high risk to breast cancer West, A.
 1998
 34 S5 p. S121-
1 p.
 artikel
412 Psychosocial impact of endocrine therapy for breast cancer on women's quality of life Leaity, S.
 1998
 34 S5 p. S121-
1 p.
 artikel
413 Psychosocial implications of prophylactic bilateral mastectomy Hatcher, M.B.
 1998
 34 S5 p. S120-
1 p.
 artikel
414 Psychosocial oncology: Where are we now? Cull, Ann
 1998
 34 S5 p. S120-
1 p.
 artikel
415 Quality assurance in surgical management Mansel, R.E.
 1998
 34 S5 p. S4-
1 p.
 artikel
416 Quality of life — An essential aspect in the follow-up care of patients with breast cancer Bastian, U.
 1998
 34 S5 p. S122-
1 p.
 artikel
417 Quality of life of breast cancer patients in different clinical phases Chie, W.C.
 1998
 34 S5 p. S123-
1 p.
 artikel
418 Quality of life of patients with early stage breast cancer treated with breast conservative surgery and postoperative irradiation Amichetti, M.
 1998
 34 S5 p. S57-
1 p.
 artikel
419 QU.A.RT. versus SSM + TRAM flap immediate breast reconstruction in T2 > 3cm n0-1 m0 breast cancer: Preliminary data D'Aiuto, G.
 1998
 34 S5 p. S26-
1 p.
 artikel
420 Radiation induced brachial plexopathy in early breast cancer Miller, N.
 1998
 34 S5 p. S60-
1 p.
 artikel
421 Radiation therapy without boost for breast conserving surgery patients with positive surgical margin or extensive intraductal component Mivauchi, K.
 1998
 34 S5 p. S62-
1 p.
 artikel
422 Radiosurgery of T1 breast cancer: A dosimetry study Formenti, C.
 1998
 34 S5 p. S58-
1 p.
 artikel
423 Randomised adjuvant trial comparing two dose intensities of epirubicin and cyclophosphamide (EC) in high-risk breast cancer Konecnv, G.
 1998
 34 S5 p. S41-
1 p.
 artikel
424 Randomised trial of long-term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone in patients with early-stage breast cancer treated with breast-conserving surgery Dalberg, Kristina
 1998
 34 S5 p. S40-
1 p.
 artikel
425 Receptor findings and menstrual status at radical operations due to breast carcinoma Kocić, M.
 1998
 34 S5 p. S110-
1 p.
 artikel
426 Reconstructive surgery using titanium plate for osseous defect after wide resection of chest wall for locoregional recurrence of breast cancer Noda, S.
 1998
 34 S5 p. S28-
1 p.
 artikel
427 Recurrent breast cancer after conservative surgery: Role of contrast enhanced MR imaging Grandinetti, M.L
 1998
 34 S5 p. S76-
1 p.
 artikel
428 Reduction of calcifications and breast cancer: Description of a case Armocida, C.
 1998
 34 S5 p. S79-S80
2 p.
 artikel
429 Relationship between estrogen receptor (ER) status in primary breast cancer (BC) specimens and serum CA15-3 levels at first relapse of disease 1998
 34 S5 p. S105-
1 p.
 artikel
430 Relationship between tumor shrinkage and changes kinetic cell activity after primary chemotherapy (PC) in breast cancer (BC) patients Bottini, A.
 1998
 34 S5 p. S105-
1 p.
 artikel
431 Results of mammographic screening 1994–1997 Baldi, V.
 1998
 34 S5 p. S95-
1 p.
 artikel
432 Results of screening in a positive family history clinic Lamont, M.
 1998
 34 S5 p. S95-
1 p.
 artikel
433 Return of touch sensibility in the breast after immediate free microvascular tram reconstruction Korvenoja, M.-L
 1998
 34 S5 p. S28-
1 p.
 artikel
434 R2: Index of biological aggressive breast cancer Cherubini, M.
 1998
 34 S5 p. S110-
1 p.
 artikel
435 Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression Elkhuizen, P.H.M.
 1998
 34 S5 p. S96-
1 p.
 artikel
436 Risks and benefits of hormone replacement therapy Raju, K. Shanti
 1998
 34 S5 p. S35-
1 p.
 artikel
437 Risks and benefits of hormone replacement therapy Pecorelli, S.
 1998
 34 S5 p. S35-
1 p.
 artikel
438 Russia (St.-Petersburg)/WHO randomized prospective study of the role of BSE in reduction of breast cancer mortality Semiglazov, V.
 1998
 34 S5 p. S92-
1 p.
 artikel
439 Screening women with a family history of breast cancer — Results from a national audit Macmillan, R.D.
 1998
 34 S5 p. S92-S93
2 p.
 artikel
440 Screening — Yes, but whom and when? von Kleist, S.
 1998
 34 S5 p. S93-
1 p.
 artikel
441 Second- and third-line treament of metastatic breast cancer with gemcitabine Brodowicz, T.
 1998
 34 S5 p. S44-
1 p.
 artikel
442 Second-degree family history and breast cancer de Souza, R.M.
 1998
 34 S5 p. S25-
1 p.
 artikel
443 Sequential administration of paclitaxel and doxorubicln followed by CMF in women with advanced breast cancer Papadimitriou, Ch.
 1998
 34 S5 p. S14-
1 p.
 artikel
444 Sequential doxorubicine (DOX) and docetaxel (DOC) as neoadjuvant chemotherapy in locally advanced breast cancer (LABC): A pilot study Wynendaele, W.
 1998
 34 S5 p. S15-
1 p.
 artikel
445 Sequential or simultaneous chemo-radiotherapy in operable breast cancer. A French multicentric phase III study — State of inclusions Noguès, C.
 1998
 34 S5 p. S44-S45
2 p.
 artikel
446 Serum and nipple aspirate levels of vitamin A and vitamin E and lack of an association with breast cancer Hargreaves, D.F.
 1998
 34 S5 p. S24-
1 p.
 artikel
447 Serum hepatocyte growth factor (HGF) levels in patients with progressive metastatic breast cancer Maemura, M.
 1998
 34 S5 p. S14-
1 p.
 artikel
448 Serum soluble VCAM: A surrogate marker of angiogenesis Byrne, G.J.
 1998
 34 S5 p. S117-
1 p.
 artikel
449 Serum tumor markers in metastatic breast cancer comparative study between CEA, CA-15.3 and MCA Carneiro, C.
 1998
 34 S5 p. S43-
1 p.
 artikel
450 Significance of blood flow analysis using color doppler ultrasound for prediction of relapse in patients with breast cancer Konishi, Y.
 1998
 34 S5 p. S108-
1 p.
 artikel
451 Significance of soluble interleukin-2 receptors and natural killer cells in breast cancer Cabrini, L
 1998
 34 S5 p. S104-
1 p.
 artikel
452 Skin-sparing mastectomy with immediate TRAM (Transverse reclus abdominis myocutaneous) flap reconstruction Chang, H.T.
 1998
 34 S5 p. S53-
1 p.
 artikel
453 Sonomammography an objective tool for assessment of chemotherapeutic response in locally advanced breast cancer Kumar, A.
 1998
 34 S5 p. S16-S17
2 p.
 artikel
454 Specialist registrar (SpR) training in breast and axillary examination Cunnick, G.H.
 1998
 34 S5 p. S75-
1 p.
 artikel
455 Specialist registrar (SpR) training in fine needle aspiration cytology (FNAC) of breast lumps — Can we do better? Cunnick, G.H.
 1998
 34 S5 p. S75-
1 p.
 artikel
456 Stages of breast cancer: An Israeli psychosocial medical of intervention Sadeh-Tassa, D.
 1998
 34 S5 p. S125-
1 p.
 artikel
457 Stereotactic-guided biopsy of occult breast lesions Lazzerini, M.
 1998
 34 S5 p. S79-
1 p.
 artikel
458 Stereotaxic guided excisional biopsy (ABBI®) — A new method for precise and minimal invasive breast surgery? Krämer, S.
 1998
 34 S5 p. S50-S51
2 p.
 artikel
459 Östergötland mammographic screening programme: Compliance, referral rate, and risk of interval breast cancer after a negative screen Vitak, Bedrich
 1998
 34 S5 p. S92-
1 p.
 artikel
460 Stress of daily activities and risk of breast cancer: A prospective cohort study in female twins in Finland Lillberg, Kirsi
 1998
 34 S5 p. S121-
1 p.
 artikel
461 Stromelysin-3 (ST3), from basic research to molecular medicine Rio, M.C.
 1998
 34 S5 p. S115-
1 p.
 artikel
462 Structuring communication in breast cancer care Postma-Schuit, F.C.E.
 1998
 34 S5 p. S6-
1 p.
 artikel
463 Subject index 1998
 34 S5 p. S139-S140
2 p.
 artikel
464 Subjective effects of pamidronate on pain, in patients with symptomatic bone metastases in advanced breast cancer Ferrero, G.
 1998
 34 S5 p. S126-
1 p.
 artikel
465 Successes and relapses in breast conserving therapy (bct) in early breast cancer on the base of 17 years own experiences Berner, J.
 1998
 34 S5 p. S56-
1 p.
 artikel
466 Superconservative surgery for early breast cancer: Preliminary results Thomas, R.
 1998
 34 S5 p. S49-S50
2 p.
 artikel
467 Surgeon's related quality of breast cancer surgery Herman, K.
 1998
 34 S5 p. S108-
1 p.
 artikel
468 Surgical treatment of breast carcinoma. A study of 460 cases Pricop, M.
 1998
 34 S5 p. S56-
1 p.
 artikel
469 Surgical treatment of vertebral breast cancer metastatsis Gligorov, J.
 1998
 34 S5 p. S91-
1 p.
 artikel
470 Survival patterns according to age and treatment among breast cancer patients Kroman, N.
 1998
 34 S5 p. S96-
1 p.
 artikel
471 Symptomatic status, mammographic sensitivity and screening policy Kavanagh, A.
 1998
 34 S5 p. S93-S94
2 p.
 artikel
472 Tangential breast irradiation: A comparison between 2D and 3D radiation therapy plans Aref, A.
 1998
 34 S5 p. S60-
1 p.
 artikel
473 Tc-99 Tetrofosmin scintimammography in determining prognostic characteristics of breast cancer Flanaqan, F.
 1998
 34 S5 p. S103-
1 p.
 artikel
474 Technetium-99m-sestamibi mammoscintigraphy in suspected breast cancer. Radiologic and histologic correlations in 43 surgically treated patients Lumachi, F.
 1998
 34 S5 p. S76-
1 p.
 artikel
475 Tenascin-C expression in invasion border of early breast cancer — A predictor of local and distant recurrence Jahkola, Tiina
 1998
 34 S5 p. S101-
1 p.
 artikel
476 The antioxidant status of breast cancer patients Korman, D.
 1998
 34 S5 p. S119-
1 p.
 artikel
477 The axilla — What can mammography offer? Flanagan, F.
 1998
 34 S5 p. S80-
1 p.
 artikel
478 The bio-ethical dilemma Spinsanti, S.
 1998
 34 S5 p. S84-
1 p.
 artikel
479 The Canadian Breast Cancer Initiative Mathieu, B.A.
 1998
 34 S5 p. S66-
1 p.
 artikel
480 The characteristics and management of extremely elderly patients with breast cancer Makino, H.
 1998
 34 S5 p. S46-
1 p.
 artikel
481 The dominant sentinel node in breast cancer: A new technique Chu, D.
 1998
 34 S5 p. S54-
1 p.
 artikel
482 The effect of immediate volume replacement with latissimus dorsi miniflaps on the outcome of breast-conserving surgery Rainsbury, R.M.
 1998
 34 S5 p. S47-
1 p.
 artikel
483 The efficacy of ultrasound-guided core needle biopsy for breast mass Mitsuvama, S.
 1998
 34 S5 p. S76-
1 p.
 artikel
484 The evolution of ultrasonography Rizzatto, G.
 1998
 34 S5 p. S5-
1 p.
 artikel
485 The experience of breast cancer screening Levshin, V.
 1998
 34 S5 p. S95-
1 p.
 artikel
486 The expression of new protein taking part in cancerogenesis, p65, and its correlation with steroid receptors in ductal carcinoma of female breast Niewiadomska, H.
 1998
 34 S5 p. S118-
1 p.
 artikel
487 The expression of proliferating antigen Ki67 and PCNA and products of suppressor gene p53 in primary invasive ductal carcinoma of female breast Niewiadomska, H.
 1998
 34 S5 p. S115-
1 p.
 artikel
488 The expression of thymidine phosphorylase in fibrocystic disease, fibroadenoma, papilloma and carcinoma of breast Yonenaga, F.
 1998
 34 S5 p. S112-
1 p.
 artikel
489 The frequency of metastases in the interpectoral lymphatic pathway in patients with breast cancer Jeziorski, Arkadiusz
 1998
 34 S5 p. S51-
1 p.
 artikel
490 The higher local recurrence rate after breast conserving therapy in young patients explained by larger tumour size, incomplete excision at first attempt and smaller excision volume? Vrieling, C.
 1998
 34 S5 p. S97-
1 p.
 artikel
491 The immune response to breast cancer Scholl, S.M.
 1998
 34 S5 p. S37-
1 p.
 artikel
492 The impact of local control in early breast cancer. Update of the EORTC trials Bartelink, H.
 1998
 34 S5 p. S38-
1 p.
 artikel
493 The impact of quality of life (QL) scores on survival in patients with metastatic breast cancer (MBC) Coates, Alan
 1998
 34 S5 p. S39-
1 p.
 artikel
494 The increasing of effect after discontinuation of the treatment with Taxotere in patients with breast cancer Gorbounova, V.
 1998
 34 S5 p. S21-
1 p.
 artikel
495 The influence of the boost on the cosmetic outcome after breast conserving therapy Vrieling, C.
 1998
 34 S5 p. S57-
1 p.
 artikel
496 The influence of the early childhood family climate on later breast cancer morbidity Vegelj-Pirc, M.
 1998
 34 S5 p. S125-
1 p.
 artikel
497 The local recurrence after breast conserving surgery: The prognosis and the diagnosis Izquierdo, M.
 1998
 34 S5 p. S104-
1 p.
 artikel
498 The management of ductal carcinoma in situ Silverstein, Melvin J.
 1998
 34 S5 p. S8-
1 p.
 artikel
499 The meaning of life with women after breast cancer treatment Vegelj-Pirc, M.
 1998
 34 S5 p. S125-
1 p.
 artikel
500 The Milan experience in surgical strategies for early breast cancer (overview on prospective trials with latest end-results) Salvadori, B.
 1998
 34 S5 p. S38-
1 p.
 artikel
501 The occurrence of deletions and point mutations in the estrogen receptor gene in breast cancer specimens Winstanley, John H.R.
 1998
 34 S5 p. S101-
1 p.
 artikel
502 The patient role in healing Hellemaa, C.
 1998
 34 S5 p. S31-
1 p.
 artikel
503 The patient's perception of her breast following irradiation (XRT) for early breast cancer (EBC) Amichetti, M.
 1998
 34 S5 p. S124-
1 p.
 artikel
504 The place of modern radiotherapy in loco-regional control and long-term survival in breast cancer Cutuli, B.
 1998
 34 S5 p. S88-
1 p.
 artikel
505 The place of the sentinel node mapping in the management of breast cancer: Prospective analysis — New aspects Makar, A.
 1998
 34 S5 p. S55-
1 p.
 artikel
506 The prediction of response to chemotherapy in invasive breast carcinoma by determination of histological grade Pinder, S.E.
 1998
 34 S5 p. S111-
1 p.
 artikel
507 The problem of arm oedema after axillary dissection and/or radiotherapy in breast cancer patients Jeziorski, A.
 1998
 34 S5 p. S53-
1 p.
 artikel
508 The relationship between margins of resection and the risk of local recurrence after breast conserving therapy Distante, V.
 1998
 34 S5 p. S48-S49
2 p.
 artikel
509 The relationship between nm23 gene expression and distal metastasis and prognosis in breast cancer Huisheng, Mao
 1998
 34 S5 p. S107-
1 p.
 artikel
510 The risk of breast cancer in women with affective or neurotic disorders Hierl, K.
 1998
 34 S5 p. S23-S24
2 p.
 artikel
511 The role of clinical trials and their impact on breast cancer management Tannock, Ian F.
 1998
 34 S5 p. S128-
1 p.
 artikel
512 The role of radiotherapy in breast conserving treatment of ductal carcinoma in situ (DCIS): First results of EORTC trial 10853 Julien, J.
 1998
 34 S5 p. S8-
1 p.
 artikel
513 The significance of prostate specific antigen (PSA) in breast cancer Klijn, J.G.M.
 1998
 34 S5 p. S106-S107
2 p.
 artikel
514 The specialist treatment of the axilla Kingsmore, D.B.
 1998
 34 S5 p. S48-
1 p.
 artikel
515 The structuring of a course of breast self-examination considering oncological, psychological and sociocultural aspects Chiechi, Luigi Mario
 1998
 34 S5 p. S67-
1 p.
 artikel
516 The usefull boost range (UBR) concept judges the ballistic selectivity of electron beams (EB) versus brachytherapy (BT) in the boost techniques of breast conserving therapy Van Limbergen, E.
 1998
 34 S5 p. S57-
1 p.
 artikel
517 The use of p65 in generating the prognosis in female breast cancer Niewiadomska, H.
 1998
 34 S5 p. S109-S110
2 p.
 artikel
518 The use of technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) breast scintigraphy to evaluate palpable breast masses Yeh, D.C.
 1998
 34 S5 p. S80-
1 p.
 artikel
519 The value of electron beam computertomography in the analysis of breast lesions and lymphnodemetastasis Kriegl, D.
 1998
 34 S5 p. S71-S72
2 p.
 artikel
520 The value of high-frequency ultrasound guided core-cut biopsy of breast tumors Albert, U.-S.
 1998
 34 S5 p. S71-
1 p.
 artikel
521 The value of post lumpectomy mammogram Aref, A.
 1998
 34 S5 p. S57-
1 p.
 artikel
522 The ‘ZEBRA’ study: An open randomised trial of ‘zoladex’ vs CMF as adjuvant therapy in the management of node positive stage II breast cancer in pre/peri-menopausal women aged 50 years or less Kaufmann, M.
 1998
 34 S5 p. S20-
1 p.
 artikel
523 Thymidylate synthetase levels in breast cancer: A predictor for early prognosis and outcome of adjuvant chemotherapy Yamamoto, N.
 1998
 34 S5 p. S104-S105
2 p.
 artikel
524 Timing of combined chemoradiotherapy in the conservative treatment of locally advanced breast cancer (LABC) Pierga, J.Y.
 1998
 34 S5 p. S13-
1 p.
 artikel
525 Topical use of Miltex® in patients with breast cancer's cutaneous manifestations Kasianenko, I.V.
 1998
 34 S5 p. S21-S22
2 p.
 artikel
526 Training in communication Razavi, Darius
 1998
 34 S5 p. S6-
1 p.
 artikel
527 Treatment decision making in breast cancer: The use of multimedia Molenaar, S.
 1998
 34 S5 p. S39-
1 p.
 artikel
528 Treatment of liver-metastases in patients with breast cancer Jäger, W.
 1998
 34 S5 p. S17-
1 p.
 artikel
529 Treatment of Paget's disease of the breast with radiotherapy only Chrisliaens, M.R.
 1998
 34 S5 p. S58-
1 p.
 artikel
530 Tumor density and malignant characteristics on mammography in the evaluation of tumorresponse in patients treated with preoperative chemotherapy Zonderland, H.M.
 1998
 34 S5 p. S72-
1 p.
 artikel
531 Tumour angiogenesis by vascular grading is of prognostic significance in breast cancer Hansen, S.
 1998
 34 S5 p. S102-
1 p.
 artikel
532 Tumour suppressor genes in breast cancer Børresen-Dale, A.-L.
 1998
 34 S5 p. S37-
1 p.
 artikel
533 UK National Trial assessing the impact of testing for BRCA1/2 breast/ovarian cancer predisposition genes Watson, M.
 1998
 34 S5 p. S62-S63
2 p.
 artikel
534 Ultrasound guided core biopsy of suspicious mammographic calcifications using high frequency and power Doppler ultrasound Teh, W.L.
 1998
 34 S5 p. S70-S71
2 p.
 artikel
535 Update on endocrine approaches in the treatment and prevention of breast cancer Kaufmann, M.
 1998
 34 S5 p. S81-
1 p.
 artikel
536 Urokinase-like plasminogenactivator (uPA) and plasminogenactivator-inhibitortype 1 (PAI-1) in primary breast cancer — Predictive markers for tamoxifen resistance? Kahlert, S.
 1998
 34 S5 p. S82-
1 p.
 artikel
537 Use of hormone replacement therapy and the sensitivity of screening mammography Kavanagh, A.
 1998
 34 S5 p. S92-
1 p.
 artikel
538 Use of mesh to repair the submuscolar pocket in breast reconstruction: A new possible technique Regolo, L.
 1998
 34 S5 p. S28-
1 p.
 artikel
539 Use of prevention modalities for breast cancer: A survey on 3620 self-administered questionnaires Caffo, O.
 1998
 34 S5 p. S67-
1 p.
 artikel
540 US guided fine needle aspiration biopsy of non palpable breast lesions Santoriello, A.
 1998
 34 S5 p. S78-
1 p.
 artikel
541 Using new technology to disseminate information on breast cancer to women Maguire, P.
 1998
 34 S5 p. S63-
1 p.
 artikel
542 Utility of 3D-dynamic magnetic resonance (MR) mammography for detecting the extent of primary tumor and axillary lymph node status of breast cancer patients Takeda, Y.
 1998
 34 S5 p. S78-
1 p.
 artikel
543 Variation in normal tissue complication probability with radiation technique in early breast cancer Cannev, P.A.
 1998
 34 S5 p. S58-S59
2 p.
 artikel
544 Vinorelbine in combination with 5-fluorouracil in metastatic breast cancer (MBC) Donadio, M.
 1998
 34 S5 p. S43-
1 p.
 artikel
545 Vinorelbine (VNR) + 5-fluorouracil continuous infusion (5-FU c.i.) in pretreated advanced breast cancer — Adria Medica Group Cobelli, S.
 1998
 34 S5 p. S17-
1 p.
 artikel
546 Weekly cisplatin-epirubicin-paclitaxel in advanced breast cancer: A phase I study Frasci, G.
 1998
 34 S5 p. S13-
1 p.
 artikel
547 Why do cancer doctors burn out and can it be prevented? Ramirez, A.J.
 1998
 34 S5 p. S38-S39
2 p.
 artikel
548 Women prefer breast cancer prognosis expressed as chance of cure to 10-year survival Vaidya, J.S.
 1998
 34 S5 p. S65-
1 p.
 artikel
549 Women taking hormone replacement therapy develop low grade tumours Iddon, J.
 1998
 34 S5 p. S82-
1 p.
 artikel
550 Worse survival of patients with endometrial cancer following tamoxifen treatment for breast cancer: A study with 309 second tumors Bergman, L.
 1998
 34 S5 p. S24-
1 p.
 artikel
                             550 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland